Training program for pharmacists on oral cancer medications
Part of Cancer clinical trials.
This study tests an educational program designed to help community pharmacists in Malaysia learn more about oral anticancer agents (cancer pills). By participating, you could improve your knowledge and skills to better support patients taking these medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a registered pharmacist working in a community pharmacy in Malaysia.
- You can read and understand English.
- You are comfortable using computers or tablets.
- You are willing to take part in surveys and possibly interviews.
- You have not taken part in earlier feedback sessions for this type of training.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well people with neuroendocrine tumors tolerate oral (pill) anti-cancer drugs and how these drugs affect their quality of life. It also tests a patient education program to help manage side effects and improve well-being.
This trial studies whether a team-based clinic visit program can improve how well people stick to their oral (by mouth) cancer medicines. It may help by offering extra support at the start of treatment or after a cancer comes back.
This study follows patients who take oral anticancer drugs and take part in a special monitoring program at Lyon-Sud hospital. It aims to understand what affects treatment safety and outcomes.
This study tests two ways of using telephone check-ins to help people manage side effects and emotional distress while taking oral anti-cancer pills at home. If you are starting or recently started an oral anti-cancer drug, you may be able to join.
This study compares two ways of teaching about oral cancer—through a mobile app or a website. It aims to see which method helps students learn better, which could lead to better prevention and early detection.
This study tests a set of practical support steps to help people with advanced cancer take their oral (by mouth) treatment medicines correctly. It may help improve adherence and reduce missed doses or appointments.
Hear when a new Oral Anti-Tumor Drugs trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.